Temporal muscle thickness and the survival of patients with IDH-wildtype glioblastoma: a meta-analysis
Frontiers in Oncology · 04.11.2026 · 16
DOI: 10.3389/fonc.2026.1944073 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 04.11.2026. Verfasst von Xiaxuan Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, The First Clinical College of Anhui Medical University, Hefei, China. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Temporal muscle thickness (TMT), an imaging-based surrogate of skeletal muscle mass and sarcopenia, has emerged as a potential prognostic marker in glioblastoma. However, its prognostic value in patients with isocitrate dehydrogenase wild-type (IDH-wt) glioblastoma remains uncertain. This meta-analysis evaluated the association between baseline TMT and survival outcomes in this population.
Methods
PubMed, Embase, and Web of Science were searched from inception to June 9, 2026. Cohort studies evaluating baseline TMT in relation to overall survival (OS) and/or progression-free survival (PFS) in patients with newly diagnosed IDH-wt glioblastoma were included. Hazard ratios (HRs) and 95% confidence intervals (CIs) were pooled using random-effects models accounting for the influence of potential heterogeneity.
Results
Twelve retrospective cohort studies involving 2,762 patients were included. Low baseline TMT was significantly associated with poorer OS (12 studies; HR, 1.81; 95% CI: 1.38 to 2.37; p < 0.001; I² = 81%) and PFS (4 studies; HR, 1.65; 95% CI: 1.37 to 1.99; p < 0.001; I² = 15%). The association with poorer OS remained significant across subgroups defined by geographic region, mean age, TMT cutoff method and value, follow-up duration, analytic model, MGMT methylation adjustment, and study quality, with no significant between-subgroup differences. Meta-regression identified mean age as a significant moderator (coefficient, −0.064; 95% CI, −0.122 to −0.006; p =0.03) for the association between low TMT and poor OS.
Conclusions
Low baseline TMT is associated with poorer OS and PFS in patients with newly diagnosed IDH-wt glioblastoma, although substantial between-study heterogeneity for OS warrants cautious interpretation. TMT may serve as a complementary prognostic marker, but further prospective studies are needed to establish its independent prognostic and clinical utility. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/ , identifier CRD420261455834.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Medicine, The First Clinical College of Anhui Medical University, Hefei, China.
- Department of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Zitieren
APA
Zhang, X., Zhang, Q., & Xu, Y. (2026). Temporal muscle thickness and the survival of patients with IDH-wildtype glioblastoma: a meta-analysis. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1944073
Vancouver
Zhang X, Zhang Q, Xu Y. Temporal muscle thickness and the survival of patients with IDH-wildtype glioblastoma: a meta-analysis. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1944073
BibTeX
@article{Zhang2026,
author = {Zhang, Xiaxuan and Zhang, Quanbin and Xu, Yi},
title = {Temporal muscle thickness and the survival of patients with IDH-wildtype glioblastoma: a meta-analysis},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1944073}
}
EUVIMED